Investing Ideas
/
Swedish Pharmaceuticals & Biotech Price disconnect

Swedish Pharmaceuticals & Biotech Price disconnect

Results

0 new

Stocks which the market has priced substantially different to their cash flows, which could imply risk.

4 companies

Bonesupport Holding

Market Cap: SEK 14.8b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.

BONEX

SEK 224.40

2.4%

-21.2%

Swedencare

Market Cap: SEK 3.4b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

SECARE

SEK 21.40

-2.1%

-42.2%

Cantargia

Market Cap: SEK 448.5m

A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.

CANTA

SEK 1.80

-1.6%

-39.5%

Sprint Bioscience

Market Cap: SEK 340.8m

A pharmaceutical company, engages in the development of drug candidates to treat cancer in Sweden.

SPRINT

SEK 3.41

-0.3%

479.9%